Transdiagnostic Group Intervention for Children With Behavior Problems
NCT ID: NCT02794051
Last Updated: 2016-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2016-05-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Youth PHP Pilot Transdiagnostic Treatment Implementation and Effectiveness Study
NCT04792151
Unified Protocol: Community Connections
NCT06038721
Implementation of Transdx Group for POTS
NCT03185247
Up-regulating Positive Affect in Emotional Disorders
NCT02790398
Effectiveness of Group CBT in Children With Mixed Psychiatric Disorders
NCT05519943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unified Protocol for Children
Child participants with behavior problems between the ages of 8-12 and their caregivers will participate in a transdiagnostic group therapy protocol.
Group Therapy
Participating children and their caregivers will attend 90-minute weekly group therapy sessions for 10 consecutive weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group Therapy
Participating children and their caregivers will attend 90-minute weekly group therapy sessions for 10 consecutive weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* Primary Behavior Disorder
* At least 1 English-speaking parent/legal guardian who can provide informed consent for the child
* Parent/Legal Guardian must agree to participate in the Trial
Exclusion Criteria
* has active suicidal ideation
* has homicidal ideation
* has self-harm behaviors
* has an intellectual disability
* has a pervasive developmental disability or significant developmental delay
* has an active substance use disorder
* is currently participating in individual or group psychotherapy, or
* has participated in therapy within the past year
* has a sibling that is also enrolled in the study
* Parents/Legal Guardians that:
1. are unwilling to participate in the study
2. are non-English speaking
3. have an intellectual disability
4. have a pervasive developmental disability or
5. a significant developmental delay
6. do not have legal custody of the child participant
7. do not reside in the same home as the child participant
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Colorado
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jessica Malmberg, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Colorado
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ehrenreich-May et al., 2012
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-0275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.